| Phosphorylation of the Bloom's syndrome helicase and its role in recovery from S-phase arrest SL Davies, PS North, A Dart, ND Lakin, ID Hickson Molecular and cellular biology, 2004 | 249 | 2004 |
| Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex KE Adams, AL Medhurst, DA Dart, ND Lakin Oncogene 25 (28), 3894-3904, 2006 | 226 | 2006 |
| Circulating microRNAs as potential new biomarkers for prostate cancer A Sita-Lumsden, DA Dart, J Waxman, CL Bevan British journal of cancer 108 (10), 1925-1930, 2013 | 185 | 2013 |
| Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer CE Fletcher, DA Dart, A Sita-Lumsden, H Cheng, PS Rennie, CL Bevan Human molecular genetics 21 (14), 3112-3127, 2012 | 174 | 2012 |
| Recruitment of the cell cycle checkpoint kinase ATR to chromatin during S-phase DA Dart, KE Adams, I Akerman, ND Lakin Journal of Biological Chemistry 279 (16), 16433-16440, 2004 | 174 | 2004 |
| Visualising androgen receptor activity in male and female mice DA Dart, J Waxman, EO Aboagye, CL Bevan PloS one 8 (8), e71694, 2013 | 132 | 2013 |
| The prediction of miRNAs in SARS-CoV-2 genomes: hsa-miR databases identify 7 key miRs linked to host responses and virus pathogenicity-related KEGG pathways significant for … ED Arisan, A Dart, GH Grant, S Arisan, S Cuhadaroglu, S Lange, ... Viruses 12 (6), 614, 2020 | 109 | 2020 |
| Prohibitin, a protein downregulated by androgens, represses androgen receptor activity SC Gamble, D Chotai, M Odontiadis, DA Dart, GN Brooke, SM Powell, ... Oncogene 26 (12), 1757-1768, 2007 | 109 | 2007 |
| FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth GN Brooke, RL Culley, DA Dart, DJ Mann, L Gaughan, SR McCracken, ... Cancer research 71 (3), 914-924, 2011 | 73 | 2011 |
| Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours DA Dart, B Spencer-Dene, SC Gamble, J Waxman, CL Bevan Endocrine-related cancer 16 (4), 1157-1169, 2009 | 69 | 2009 |
| Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer CE Fletcher, E Sulpice, S Combe, A Shibakawa, DA Leach, MP Hamilton, ... Oncogene 38 (28), 5700-5724, 2019 | 67 | 2019 |
| MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer M Xie, DA Dart, T Guo, XF Xing, XJ Cheng, H Du, WG Jiang, XZ Wen, ... Gastric cancer 21, 41-54, 2018 | 67 | 2018 |
| Unveiling the potential of prohibitin in cancer S Koushyar, WG Jiang, DA Dart Cancer letters 369 (2), 316-322, 2015 | 63 | 2015 |
| Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers CE Fletcher, DA Dart, CL Bevan Endocrine-related cancer 21 (5), R409-R429, 2014 | 42 | 2014 |
| Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens DA Dart, GN Brooke, A Sita-Lumsden, J Waxman, CL Bevan Oncogene 31 (43), 4588-4598, 2012 | 31 | 2012 |
| Circulating nucleic acids as biomarkers of prostate cancer A Sita-Lumsden, CE Fletcher, DA Dart, GN Brooke, J Waxman, CL Bevan Biomarkers in medicine 7 (6), 867-877, 2013 | 29 | 2013 |
| The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment DA Dart, SM Picksley, PA Cooper, JA Double, MC Bibby International journal of oncology 24 (1), 115-125, 2004 | 23 | 2004 |
| The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells S Koushyar, G Economides, S Zaat, W Jiang, CL Bevan, DA Dart Oncogenesis 6 (5), e333-e333, 2017 | 21 | 2017 |
| Mechanisms of androgen receptor repression in prostate cancer SM Powell, GN Brooke, HC Whitaker, V Reebye, SC Gamble, D Chotai, ... Biochemical Society Transactions 34 (6), 1124-1127, 2006 | 21 | 2006 |
| Insights into roles of the miR-1,-133 and-206 family in gastric cancer M Xie, DA Dart, S Owen, X Wen, J Ji, W Jiang Oncology Reports 36 (3), 1191-1198, 2016 | 20 | 2016 |
